Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Carter Bankshares (CARE) Cash & Equivalents (2020 - 2022)

Carter Bankshares' Cash & Equivalents history spans 3 years, with the latest figure at $65.7 million for Q3 2022.

  • For Q3 2022, Cash & Equivalents fell 70.9% year-over-year to $65.7 million; the TTM value through Sep 2022 reached $65.7 million, down 70.9%, while the annual FY2021 figure was $277.8 million, 14.82% up from the prior year.
  • Cash & Equivalents reached $65.7 million in Q3 2022 per CARE's latest filing, down from $70.2 million in the prior quarter.
  • In the past five years, Cash & Equivalents ranged from a high of $277.8 million in Q4 2021 to a low of $65.7 million in Q3 2022.
  • Average Cash & Equivalents over 3 years is $178.2 million, with a median of $217.9 million recorded in 2021.
  • Peak YoY movement for Cash & Equivalents: grew 14.82% in 2021, then plummeted 70.9% in 2022.
  • A 3-year view of Cash & Equivalents shows it stood at $241.9 million in 2020, then grew by 14.82% to $277.8 million in 2021, then crashed by 76.35% to $65.7 million in 2022.
  • Per Business Quant, the three most recent readings for CARE's Cash & Equivalents are $65.7 million (Q3 2022), $70.2 million (Q2 2022), and $108.0 million (Q1 2022).